163 related articles for article (PubMed ID: 16172321)
1. Etanercept and the treatment of multicentric reticulohistiocytosis.
Lovelace K; Loyd A; Adelson D; Crowson N; Taylor JR; Cornelison R
Arch Dermatol; 2005 Sep; 141(9):1167-8. PubMed ID: 16172321
[No Abstract] [Full Text] [Related]
2. Treatment of multicentric reticulohistiocytosis with etanercept.
Kovach BT; Calamia KT; Walsh JS; Ginsburg WW
Arch Dermatol; 2004 Aug; 140(8):919-21. PubMed ID: 15313806
[No Abstract] [Full Text] [Related]
3. Multicentric reticulohistiocytosis treated successfully with an anti-tumor necrosis factor agent: comment on the article by Gorman et al.
Matejicka C; Morgan GJ; Schlegelmilch JG
Arthritis Rheum; 2003 Mar; 48(3):864-6. PubMed ID: 12632456
[No Abstract] [Full Text] [Related]
4. Recalcitrant hand pompholyx: variable response to etanercept.
Ogden S; Clayton TH; Goodfield MJ
Clin Exp Dermatol; 2006 Jan; 31(1):145-6. PubMed ID: 16309517
[No Abstract] [Full Text] [Related]
5. Effectiveness of a once weekly double dose of etanercept in patients with juvenile idiopathic arthritis: a clinical study.
Prince FH; Twilt M; Jansen-Wijngaarden NC; van Suijlekom-Smit LW
Ann Rheum Dis; 2007 May; 66(5):704-5. PubMed ID: 17324973
[No Abstract] [Full Text] [Related]
6. Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatment.
Tüzün E; Meriggioli MN; Rowin J; Yang H; Christadoss P
J Autoimmun; 2005 May; 24(3):261-8. PubMed ID: 15848049
[TBL] [Abstract][Full Text] [Related]
7. Etanercept: an epidural steroid alternative for minimally invasive treatment of radiculitis.
Huntoon MA
Anesthesiology; 2009 May; 110(5):967-9. PubMed ID: 19352155
[No Abstract] [Full Text] [Related]
8. Successful etanercept desensitization in a patient with severe injection site reactions.
Hall J; Findeisen J
J Clin Rheumatol; 2013 Oct; 19(7):407-8. PubMed ID: 24048103
[No Abstract] [Full Text] [Related]
9. Healing of erosive disease in multicentric reticulohistiocytosis.
Broadwell AW; Calamia KT; Kransdorf MJ; Ginsburg WW
J Rheumatol; 2010 Jun; 37(6):1366-7. PubMed ID: 20516048
[No Abstract] [Full Text] [Related]
10. Effect of etanercept on insulin secretion and insulin sensitivity in a randomized trial with psoriatic patients at risk for developing type 2 diabetes mellitus.
Martínez-Abundis E; Reynoso-von Drateln C; Hernández-Salazar E; González-Ortiz M
Arch Dermatol Res; 2007 Nov; 299(9):461-5. PubMed ID: 17726611
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
Tyring S; Gordon KB; Poulin Y; Langley RG; Gottlieb AB; Dunn M; Jahreis A
Arch Dermatol; 2007 Jun; 143(6):719-26. PubMed ID: 17576937
[TBL] [Abstract][Full Text] [Related]
12. Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model.
Bodar EJ; van der Hilst JC; Drenth JP; van der Meer JW; Simon A
Neth J Med; 2005; 63(7):260-4. PubMed ID: 16093577
[TBL] [Abstract][Full Text] [Related]
13. Perineural injection of etanercept as a treatment for postamputation pain.
Dahl E; Cohen SP
Clin J Pain; 2008 Feb; 24(2):172-5. PubMed ID: 18209523
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary sarcoidosis associated with etanercept therapy.
Farah RE; Shay MD
Pharmacotherapy; 2007 Oct; 27(10):1446-8. PubMed ID: 17896899
[TBL] [Abstract][Full Text] [Related]
15. Etanercept in the treatment of vitiligo.
Rigopoulos D; Gregoriou S; Larios G; Moustou E; Belayeva-Karatza E; Kalogeromitros D
Dermatology; 2007; 215(1):84-5. PubMed ID: 17587849
[No Abstract] [Full Text] [Related]
16. Evaluating the tolerability and efficacy of etanercept compared to triamcinolone acetonide for the intralesional treatment of keloids.
Berman B; Patel JK; Perez OA; Viera MH; Amini S; Block S; Zell D; Tadicherla S; Villa A; Ramirez C; De Araujo T
J Drugs Dermatol; 2008 Aug; 7(8):757-61. PubMed ID: 18720692
[TBL] [Abstract][Full Text] [Related]
17. Improvement in patient-reported outcomes for patients with ankylosing spondylitis treated with etanercept 50 mg once-weekly and 25 mg twice-weekly.
Braun J; McHugh N; Singh A; Wajdula JS; Sato R
Rheumatology (Oxford); 2007 Jun; 46(6):999-1004. PubMed ID: 17389658
[TBL] [Abstract][Full Text] [Related]
18. A recalcitrant acrodermatitis continua of Hallopeau successfully treated with etanercept.
Silpa-archa N; Wongpraparut C
J Med Assoc Thai; 2011 Sep; 94(9):1154-7. PubMed ID: 21970208
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis.
Don BR; Spin G; Nestorov I; Hutmacher M; Rose A; Kaysen GA
J Pharm Pharmacol; 2005 Nov; 57(11):1407-13. PubMed ID: 16259772
[TBL] [Abstract][Full Text] [Related]
20. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
Gisondi P; Del Giglio M; Cotena C; Girolomoni G
Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
